Liraglutide does not boost thyroid cancer risk in monkeys even when they are given enormous doses, he says.
FORBES: Drug Safety
Another GLP-1 analog is liraglutide, sold by Nova Nordisk (NYSE:NVO) as Victoza.
FORBES: Diabetes Market Booms As Substitutes Sought For Daily Insulin Dosing
Thomsen says new data from recently completed two-year human studies of liraglutide show no hints of thyroid problems in roughly 1, 500 patients.
Should it demand additional, longer-term human studies of liraglutide before approving the drug that could reassure people that the risk is low?
应用推荐
模块上移
模块下移
不移动